| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/05/2007 | CN101028340A Medicinal composition containing siegesbeckia orientalis and its preparation |
| 09/05/2007 | CN101028338A Oral-cavity disintegrant tablet for treating cardiovascular disease |
| 09/05/2007 | CN101028330A Medicinal composition for treating cardiovascular disease, its production and use |
| 09/05/2007 | CN101028328A Production and use for kaki-leaf extract |
| 09/05/2007 | CN101028327A Xie Bao oral liquid and its production |
| 09/05/2007 | CN101028319A Chinese-medicine compound preparation against coronary heart disease and its production |
| 09/05/2007 | CN101028303A Chinese medicine for treating hypertension |
| 09/05/2007 | CN101028299A Chinese medicine for treating cardiopathy |
| 09/05/2007 | CN101028275A Use of alpha-D-glucose diglyceride in preparation of thrombolytic medicine |
| 09/05/2007 | CN101028268A Pharmaceutical compositions |
| 09/05/2007 | CN101028266A Lung medicine-feeding preparation containing Mulinong |
| 09/05/2007 | CN101028259A Water soluble paclitaxel product |
| 09/05/2007 | CN101028122A Sweet dumplings with cardiovascular health-care function and its production |
| 09/05/2007 | CN101028119A Dumplings with cardiovascular health-care function and its production |
| 09/05/2007 | CN101028117A Steamed stuffed bun with cardiovascular health-care function |
| 09/05/2007 | CN101028100A Production of edible cactus nutrient cellulose |
| 09/05/2007 | CN100335897C Quality detection method for compound prepn of red sage and notoginseng |
| 09/05/2007 | CN100335480C New imidazopyrdine derivatives, its preparation method and medicine composition containing same |
| 09/05/2007 | CN100335479C Bicyclic inhibitors of glycogen synthase kinase 3 |
| 09/05/2007 | CN100335464C Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 09/05/2007 | CN100335461C Arylsulfonanilide ureas |
| 09/05/2007 | CN100335135C Ginkgo leaf extract capsule composition and its prepn |
| 09/05/2007 | CN100335134C Nimodipine soft capsule and its prepn |
| 09/05/2007 | CN100335128C Formulations for the rectal administration of thrombolytically-active agents |
| 09/05/2007 | CN100335089C Chinese medicine capsule for treating transient cerebral ischemia symdrome |
| 09/05/2007 | CN100335085C Chinese medicinal capsule for treating apoplexy and its preparation method |
| 09/05/2007 | CN100335076C Art for extracting red sage root water soluble ingredient and removing impurities |
| 09/05/2007 | CN100335074C Chinese medicine oral liquid for treating apoplexia |
| 09/05/2007 | CN100335064C Pueraria flavone micro pill prepn and its prepn process |
| 09/04/2007 | USRE39820 Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
| 09/04/2007 | US7265227 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 09/04/2007 | US7265226 Interact with opoid receptors; decreasing metabolic rates of the phenolic piperidines by amidation, imidation, or forming a formamide, a hydroxyamidine or a thioamide; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction |
| 09/04/2007 | US7265156 Medicinal association of a biguanine and a carrier, for example metformin and arginine |
| 09/04/2007 | US7265142 Materials and methods for the treatment of hypertension and angina |
| 09/04/2007 | US7265139 RXR activating molecules |
| 09/04/2007 | US7265137 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 09/04/2007 | US7265136 Substituted stilbene compounds with vascular damaging activity |
| 09/04/2007 | US7265132 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 09/04/2007 | US7265125 4-Heteroaminoquinazoline derivatives,.e.g., 2-methyl-4-piperidin-1-yl-7-pyridin-3-yl-quinazoline; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity. |
| 09/04/2007 | US7265124 Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound |
| 09/04/2007 | US7265119 For therapy of nicotine dependency |
| 09/04/2007 | US7265113 Anticancer agents; antiinflammatory agents, for therapy of rheumatoid arthritis |
| 09/04/2007 | US7265108 For example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 09/04/2007 | US7264935 Potassium-dependent sodium-calcium exchanger |
| 09/04/2007 | US7264813 Therapeutic uses of Dunaliella powder |
| 09/04/2007 | US7264799 Administering to patient before or simultaneously with surgery at least one heparinase enzyme, wherein heparinase enzyme decreases localized inflammatory response in the tissue of the patient |
| 09/04/2007 | CA2444554C Pharmaceutical compositions of amlodipine and atorvastatin |
| 09/04/2007 | CA2397828C Compounds having hypolipidemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them |
| 09/04/2007 | CA2304702C Oral compositions of levosimendan |
| 09/04/2007 | CA2297911C Substituted 6-phenylphenanthridines |
| 08/30/2007 | WO2007098390A2 Method for treating resistant hypertension |
| 08/30/2007 | WO2007098387A2 Antihypertensive therapy |
| 08/30/2007 | WO2007098352A2 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors |
| 08/30/2007 | WO2007097961A1 Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage |
| 08/30/2007 | WO2007097929A1 Compounds and methods for treatment of stroke |
| 08/30/2007 | WO2007097707A1 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives |
| 08/30/2007 | WO2007097301A1 Prophylactic or therapeutic agent for cerebral ischemia or cerebral ischemic reperfusion injury in stroke |
| 08/30/2007 | WO2007097205A1 Eyedrops |
| 08/30/2007 | WO2007096362A1 Heterocyclic compounds and their use in the treatment of cardiovascular disease |
| 08/30/2007 | WO2007096078A1 Use of resveratrol and derivatives thereof for promoting the wellness state in mammals |
| 08/30/2007 | WO2007096072A2 New pyridin-3-amine derivatives |
| 08/30/2007 | WO2007095789A1 Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof |
| 08/30/2007 | WO2007077457A3 Treatment of equine laminitis with 5-ht1b/ 1d antagonists |
| 08/30/2007 | WO2007065539A8 Extracts of gynostemma and compositions for reducing blood lipid levels |
| 08/30/2007 | WO2007060206A3 Further crystalline forms of rostafuroxin |
| 08/30/2007 | WO2007020533A3 Process for the preparation of losartan potassium |
| 08/30/2007 | US20070203353 Bipolar trans carotenoid salts and their uses |
| 08/30/2007 | US20070203338 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 08/30/2007 | US20070203337 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/30/2007 | US20070203248 Cardioprotective agents |
| 08/30/2007 | US20070203246 Combinations of Cholesterol Ester Transfer Protein Inhibitors and HMG COA Reductase Inhibitors for Cardiovascular Indications |
| 08/30/2007 | US20070203193 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 08/30/2007 | US20070203184 Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them |
| 08/30/2007 | US20070203141 Method for administering birb 796 bs |
| 08/30/2007 | US20070203139 Aryl Glycinamide Derivatives And Their Use As Nk1 Antagonists And Serotonin Reuptake Inhibitors |
| 08/30/2007 | US20070203090 N-pyrazole A2A receptor agonists |
| 08/30/2007 | US20070203063 Pharmaceutical compositions including variants of vascular endothelial cell growth factor having altererd pharmacological properties |
| 08/30/2007 | US20070203061 Adiponectin expression-inducing agents and uses thereof |
| 08/30/2007 | US20070202198 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors biofilters and bioreactors |
| 08/30/2007 | US20070202174 New mandelic acid derivatives and their use as thrombin inhibitors |
| 08/30/2007 | US20070202160 Solid-state form of celecoxib having enhanced bioavailability |
| 08/30/2007 | US20070202100 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 08/30/2007 | US20070202099 Antibody Drug |
| 08/30/2007 | DE102005055726A1 Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Hydroxy-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use |
| 08/30/2007 | CA2643012A1 Heterocyclic compounds and their use in the treatment of cardiovascular disease |
| 08/30/2007 | CA2642933A1 Prophylactic or therapeutic agent for cerebral ischemia or cerebral ischemic reperfusion injury in stroke |
| 08/30/2007 | CA2642685A1 Antihypertensive therapy |
| 08/30/2007 | CA2642587A1 Compounds and methods for treatment of stroke |
| 08/30/2007 | CA2640723A1 Aliskiren nitrate salt |
| 08/30/2007 | CA2638124A1 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives |
| 08/30/2007 | CA2637620A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors |
| 08/29/2007 | EP1826207A1 Acid salt of benzimidazole derivative and crystal thereof |
| 08/29/2007 | EP1825864A2 Antithrombotic agents |
| 08/29/2007 | EP1825850A1 Use of resveratrol and derivatives thereof for promoting the wellness state in mammals |
| 08/29/2007 | EP1824979A2 Methods, products and uses involving platelets and/or the vasculature |
| 08/29/2007 | EP1824863A1 Silicon compounds and their use |
| 08/29/2007 | EP1824862A1 Silicon compounds and their use |
| 08/29/2007 | EP1824855A1 Novel pyrrolo [3, 2-d]pyrimidin-4-one derivatives and their use in therapy |
| 08/29/2007 | EP1824838A1 Novel compounds |
| 08/29/2007 | EP1824833A2 Preparation of telmisartan salts with improved solubility |